Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,600.00
-360.00 (-6.04%)
Aug 14, 2025, 3:30 PM KST

Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 537.82 billion as of August 14, 2025. Its market cap has decreased by -24.33% in one year.

Market Cap
537.82B
Enterprise Value
481.96B
Revenue
10.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,600.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 537.82B, an increase of 1,032.39%. That is a compound annual growth rate of 11.41%.

History

DateMarket Cap% Change
Aug 14, 2025537.82B-4.28%
Dec 30, 2024561.85B-45.92%
Dec 28, 20231,038.98B-4.44%
Dec 29, 20221,087.24B11.39%
Dec 30, 2021976.10B-6.92%
Dec 30, 20201,048.68B115.45%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 73.45T
Celltrion 38.01T
ALTEOGEN 22.98T
Yuhan 8,383.50B
SK Biopharmaceuticals 7,737.35B
Peptron 6,989.21B
PharmaResearch 6,950.67B
LigaChem Biosciences 5,419.69B
Market Cap Rankings